Evolus Inc. (EOLS)
NASDAQ: EOLS
· Real-Time Price · USD
9.69
0.13 (1.36%)
At close: May 23, 2025, 3:59 PM
9.52
-1.75%
After-hours: May 23, 2025, 04:09 PM EDT
Evolus Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Product Revenue | 264.31M | 199.72M | 146.59M | 98.97M | 55.8M | 34.24M |
| Product Revenue Growth | +32.34% | +36.24% | +48.12% | +77.36% | +62.99% | n/a |
| Service Revenue | 1.97M | 2.36M | 2.02M | n/a | n/a | n/a |
| Service Revenue Growth | -16.75% | +16.80% | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 |
|---|---|
| Non-Us Revenue | 13.12M |
| Non-Us Revenue Growth | n/a |
| United States Revenue | 253.16M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 56.64M | 50.24M | 52.51M | 50.15M | 45.12M | 43.06M | 43.33M | 41.17M | 37.38M | 36.73M | 34.79M | 36.88M | 33.44M | 33.28M | 31.68M | 26.47M | 20.68M | 27.39M | 21.94M | 17.55M | 31.3M | 30.29M | 30.9M | 34.89M | 17.52M | 12.22M | 7.21M | 6.25M | 3.47M | 1.65M | 1.15M | 803K | 1.22M | 922K | 989K | 2.56M | 2.56M |
| Selling, General, and Administrative Revenue Growth | +12.73% | -4.31% | +4.69% | +11.15% | +4.80% | -0.62% | +5.23% | +10.14% | +1.78% | +5.56% | -5.64% | +10.27% | +0.49% | +5.03% | +19.69% | +28.03% | -24.52% | +24.84% | +25.02% | -43.92% | +3.35% | -1.98% | -11.45% | +99.17% | +43.34% | +69.54% | +15.38% | +80.21% | +110.12% | +43.35% | +43.34% | -33.91% | +31.78% | -6.77% | -61.38% | 0.00% | n/a |
| Research and Development Revenue | 2.21M | 2.43M | 2.31M | 2.35M | 2.08M | 2.38M | 1.59M | 1.21M | 1.38M | 1.35M | 1.38M | 3.55M | 468K | 423K | 301K | 499K | 841K | 719K | 350K | 145K | 507K | 418K | 693K | 509K | 2.35M | 1.18M | 1.98M | 1.65M | 1.68M | 1.21M | 1.47M | 1.36M | 2.65M | 2.68M | 3.06M | 3.43M | 3.43M |
| Research and Development Revenue Growth | -8.97% | +5.01% | -1.53% | +13.09% | -12.69% | +49.97% | +31.37% | -12.53% | +2.45% | -2.03% | -61.24% | +658.55% | +10.64% | +40.53% | -39.68% | -40.67% | +16.97% | +105.43% | +141.38% | -71.40% | +21.29% | -39.68% | +36.15% | -78.37% | +98.73% | -40.11% | +19.96% | -1.79% | +38.91% | -17.54% | +7.33% | -48.51% | -1.12% | -12.33% | -10.95% | 0.00% | n/a |